A multicenter research team has established the protocol for a randomized, sham-controlled clinical trial investigating whether transcutaneous electrical acupoint stimulation at the P6 acupoint can reduce postoperative nausea and vomiting among female patients undergoing gynecologic laparoscopic surgery under general anesthesia. The study is designed to evaluate the effect of transcutaneous electrical acupoint stimulation at the P6 acupoint on postoperative nausea and vomiting prevention in patients receiving dexamethasone or amisulpride.
Postoperative nausea and vomiting continues to present a frequent clinical complication following gynecologic laparoscopy. Current clinical practice guidelines recommend multimodal prophylaxis to mitigate these symptoms, yet routine management remains predominantly reliant on pharmacologic antiemetics alone. Transcutaneous electrical acupoint stimulation applied to the P6 acupoint has demonstrated potential utility for preventing postoperative nausea and vomiting, but substantial uncertainty persists regarding its additive effectiveness when combined with pharmacologic agents, as well as whether its protective effect varies according to the specific antiemetic administered.
To address these questions, the investigators designed a prospective, multicenter, 2 × 2 factorial trial that will enroll 212 women undergoing gynecologic laparoscopic procedures under general anesthesia. Participants will be randomly allocated in an equal 1:1:1:1 ratio across four distinct intervention arms: active transcutaneous electrical acupoint stimulation paired with dexamethasone, active transcutaneous electrical acupoint stimulation paired with amisulpride, sham electrical stimulation paired with dexamethasone, or sham electrical stimulation paired with amisulpride.
Under the trial protocol, transcutaneous electrical acupoint stimulation and sham stimulation will be delivered at the P6 acupoint across two one-hour sessions. The initial intervention session is scheduled to take place before surgery, while the second one-hour stimulation session will be delivered at 24 hours after surgery.
The primary outcome of the trial is the cumulative incidence of postoperative nausea and vomiting observed within 48 hours following surgical intervention. Key secondary outcomes include postoperative nausea and vomiting-related symptoms and severity, the use of rescue antiemetics, opioid consumption, pain scores, recovery milestones, patient satisfaction, Quality of Recovery-15 scores, and length of hospital stay.
Safety monitoring will systematically track adverse events directly attributable to electrical acupoint stimulation or the pharmacologic study drugs, as well as perioperative hemodynamic instability requiring clinical intervention. In its planned analysis, the study will test transcutaneous electrical acupoint stimulation against sham stimulation as its primary comparison, while generating exploratory estimates for the comparison between dexamethasone and amisulpride and testing for potential drug-stimulation interaction effects under ClinicalTrials.gov registration identifier NCT07631910.
Ultimately, the authors anticipate that the trial’s findings will help address current uncertainties regarding combined prophylactic approaches and inform integrated prevention strategies for postoperative nausea and vomiting in women undergoing gynecologic laparoscopic surgery.
Subject of Research: Prevention of postoperative nausea and vomiting using transcutaneous electrical acupoint stimulation in gynecologic laparoscopic surgery
Article Title: Transcutaneous electrical acupoint stimulation versus sham stimulation and dexamethasone versus amisulpride for preventing postoperative nausea and vomiting after laparoscopic gynecologic surgery: protocol for a randomized 2 × 2 factorial trial
Article References: Li, Y., Zhang, J., Xu, Y., Liu, Q., Yang, L., Fang, F., Yu, Y., & Chen, Z. (2026). Transcutaneous electrical acupoint stimulation versus sham stimulation and dexamethasone versus amisulpride for preventing postoperative nausea and vomiting after laparoscopic gynecologic surgery: protocol for a randomized 2 × 2 factorial trial. Frontiers in Pharmacology, 17, Article 1934841. https://doi.org/10.3389/fphar.2026.1934841
Image Credits: AI Generated
DOI: 10.3389/fphar.2026.1934841
Keywords: postoperative nausea and vomiting, transcutaneous electrical acupoint stimulation, P6 acupoint, laparoscopic surgery, gynecologic surgery, dexamethasone, amisulpride, clinical trial protocol, Transcutaneous, electrical, acupoint, stimulation
News Source: Ophelia Keating. (November 10, 2026). Trial Protocol Evaluates Acupoint Stimulation For Preventing Postoperative Nausea In Gynecologic Surgery. Scienmag.



